National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST), Chiba, Japan; Group of Quantum-state Controlled MRI, QST, Chiba, Japan; Graduate School of Medicine, Tokushima University, Tokushima, Japan.
National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST), Chiba, Japan; Group of Quantum-state Controlled MRI, QST, Chiba, Japan.
Nanomedicine. 2018 Jun;14(4):1315-1324. doi: 10.1016/j.nano.2018.03.006. Epub 2018 Apr 4.
The enhanced permeability and retention (EPR) effect is variable depending on nanoparticle properties and tumor/vessel conditions. Thus, intratumoral evaluations of the vasculature and nanoparticle distribution are important for predicting the therapeutic efficacy and the intractability of tumors. We aimed to develop a tumor vasculature evaluation method and high-resolution nanoparticle delivery imaging using magnetic resonance (MR) micro-imaging technology with a gadolinium (Gd)-dendron assembled liposomal contrast agent. Using the Gd-liposome and a cryogenic receiving coil, we achieved 50-μm isotropic MR angiography with clear visualization of tumor micro-vessel structure. The Gd-liposome-enhanced MR micro-imaging revealed differences in the vascular structures between Colon26- and SU-DHL6-grafted mice models. The vessel volumes and diameters measured for both tumors were significantly correlated with histological observations. The MR micro-imaging methods facilitate the evaluation of intratumoral vascularization patterns, the quantitative assessment of vascular-properties that alter tumor malignancy, particle retentivity, and the effects of treatment.
增强的通透性和保留(EPR)效应取决于纳米颗粒的性质和肿瘤/血管的状态,因此,对肿瘤内血管和纳米颗粒分布的评估对于预测治疗效果和肿瘤的难治性非常重要。我们旨在开发一种肿瘤血管评估方法,并使用带有钆(Gd)-树枝状聚集体脂质体对比剂的磁共振(MR)微成像技术进行高分辨率的纳米颗粒递药成像。使用 Gd-脂质体和低温接收线圈,我们实现了 50μm 各向同性的 MR 血管造影术,能够清晰显示肿瘤微血管结构。Gd-脂质体增强的 MR 微成像显示了 Colon26 和 SU-DHL6 移植瘤模型之间血管结构的差异。两种肿瘤的血管体积和直径的测量结果与组织学观察结果具有显著相关性。MR 微成像方法有助于评估肿瘤内血管生成模式、定量评估改变肿瘤恶性程度的血管特性、颗粒保留率以及治疗效果。